quetiapine pharmathen 50 mg prolonged-release tablets
sandoz d.d. - quentiapine - 50 mg prolonged-release tablets
quetiapine pharmathen 150 mg prolonged-release tablets
sandoz d.d. - quentiapine - 150 mg prolonged-release tablets
quetiapine pharmathen 200 mg prolonged-release tablets
sandoz d.d. - quentiapine - 200 mg prolonged-release tablets
quetiapine pharmathen 300 mg prolonged-release tablets
sandoz d.d. - quentiapine - 300 mg prolonged-release tablets
quetiapine pharmathen 400 mg prolonged-release tablets
sandoz d.d. - quentiapine - 400 mg prolonged-release tablets
memantine lek
pharmathen s.a. - мемантин хидрохлорид - Болест на Алцхаймер - psychoanaleptics и други анти-деменция лекарства - Лечение на пациенти с умерена до тежка болест на Алцхаймер.
venturax 20 mg/ml + 5 mg/ml eye drops, solution
pharmathen s.a. - Тимолол, комбинации - 20 mg/ml + 5 mg/ml eye drops, solution
baxogar 150 mg film - coated tablets
pharmathen s.a. - Ибандронатом - 150 mg film - coated tablets
clopidogrel viatris (previously clopidogrel taw pharma)
viatris limited - клопидогрел безилат - peripheral vascular diseases; stroke; myocardial infarction - Антитромботични агенти - secondary prevention of atherothrombotic events clopidogrel is indicated in:adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. adult patients suffering from acute coronary syndrome. non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). Възхода на сегмента st остър инфаркт на миокарда, в комбинация с ВЪЗХОДЯЩО в лечението на пациенти, които имат право на тромболитической терапия. in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is) clopidogrel in combination with asa is indicated in:adult patients with moderate to high-risk tia (abcd2 score ≥4) or minor is (nihss ≤3) within 24 hours of either the tia or is event. prevention of atherothrombotic and thromboembolic events in atrial fibrillation:in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. За повече информация, моля, вижте раздел 5.
poulvac ibmm ark – Лиофилизат за разтвор за фино капково разпръскване при бройлери 103.3 eid50*
zoetis belgium sa - Вирус на птичи инфекциозен бронхит (щам на Масачузетс 1263 прецежда се и се Арканзас 3168) - Лиофилизат за разтвор за фино капково разпръскване. - 103.3 eid50* - бройлери